Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2020
Reporting Period: Single event date (January 8, 2020)
Context: The filing discloses a Regulation FD investor presentation related to an offering of common stock. The company is registered on the NYSE American under the symbols YCBD and YCBD PR A.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a disclosure notice for an investor presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are detailed in this specific filing text. The primary event is the furnishing of an investor presentation (Exhibit 99.1) associated with a preliminary prospectus supplement for a common stock offering.
Guidance, Outlook, and Risks
- Management Commentary: The filing incorporates by reference an investor presentation made available during the offering process. Specific commentary, guidance, or outlook details are contained within the attached Exhibit 99.1 and are not summarized in the body of this 8-K.
- Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
- Emerging Growth Company: The registrant has elected to be classified as an emerging growth company.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor Presentation dated January 8, 2020) for specific financial projections and offering details.
- Verify the terms of the common stock offering referenced in the preliminary prospectus supplement.
- Confirm the status of the 8.0% Series A Cumulative Convertible Preferred Stock (YCBD PR A) listed in the filing.
- Check subsequent filings for the final results of the offering mentioned in this report.